Purchase Order 75N92E21P00115

<p>The National Human Genome Research Institute awarded a purchase order to Tecan Genomics, Inc. for $16,491.00 on December 2, 2020, for tissue and material, with an ultimate completion date of January 1, 2021. Performance is in North Bethesda, Maryland. No small business set-aside was applied to this firm fixed-price order.</p>

<p>The National Human Genome Research Institute issued a purchase order to Tecan Genomics, Inc. on August 30, 2017, for $5,476.00 under firm fixed-price terms. Performance will take place in North Bethesda, Maryland, with an ultimate completion date of September 30, 2017. No set-aside applied.</p>

<p>The National Human Genome Research Institute issued a purchase order to Tecan U.S., Inc. valued at $3,307.73 on February 26, 2016, for laboratory automation equipment and services.</p> <p>Work is performed at Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of December 21, 2020. No set-aside was applied to this acquisition.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $19,792.44 on August 15, 2018, for DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software. Performance is at North Bethesda, Maryland, with an ultimate completion date of September 14, 2018. The order carries firm fixed price terms and no set-aside designation.</p>

Tecan Genomics Inc. has been awarded a firm fixed-price purchase order valued at fifteen thousand seven hundred twenty-three dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide RNA sequencing services. Specifically, the prime contractor will deliver universal plus total RNA sequencing with NuQuant human any deplete analysis for the NIH's infectious disease programs. Performance will take place in Redwood City, California over a four...

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on July 19, 2018, for $3,038.08, with an ultimate completion date of September 9, 2019. Work is performed in North Bethesda, Maryland. The order is a firm fixed price acquisition for commercial laboratory supplies or reagents supporting genomic research infrastructure. No small business set-aside applies.</p>

<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>

<p>The National Human Genome Research Institute issued a $15,321.60 delivery order to Illumina, Inc. on July 18, 2019, for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 2, 2020. No set-aside was used for this award.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>